Table 2.
L4-L2/3 | Effect of ACPD, % of the 1st Control IPSC |
GDPβS in the Intracellular Solution, % of the 1st Control IPSC |
L4-L4 | Effect of ACPD, % of the 1st Control IPSC |
GDPβS in the Intracellular Solution, % of the 1st Control IPSC |
||||
---|---|---|---|---|---|---|---|---|---|
Average ±SE | Control | ACPD | Control | ACPD | Average ±SE | Control | ACPD | Control | ACPD |
IPSC1 | 100 | 39.3 ± 11.2* | 100 | 57.6 ± 8.5† | IPSC1 | 100 | 46.5 ± 7.1† | 100 | 54.3 ± 5.4* |
IPSC2 | 79.5 ± 3.2 | 32.9 ± 7.8* | 74.6 ± 4.3 | 42.8 ± 4.8† | IPSC2 | 92.0 ± 9.0 | 43.6 ± 6.5† | 98.4 ± 7.8 | 55.2 ± 6.6* |
IPSC3 | 68.1 ± 3.0 | 30.9 ± 6.9* | 62.3 ± 6.4 | 39.8 ± 3.0* | IPSC3 | 84.9 ± 10.2 | 40.2 ± 6.2† | 98.4 ± 10.4 | 56.6 ± 5.5* |
IPSC4 | 59.5 ± 2.5 | 29.1 ± 6.9† | 51.7 ± 5.9 | 34.8 ± 2.8* | IPSC4 | 77.6 ± 9.5 | 37.4 ± 5.9† | 90.8 ± 9.7 | 63.7 ± 9.6* |
P < 0.05,
P < 0.01.